) has been revised to $4.08 / share. This is a decrease of 20.00% from the prior estimate of $5.10 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...
The latest price target for Century Therapeutics (NASDAQ:IPSC) was reported by Leerink Partners on November 17, 2025. The analyst firm set a price target for $2.00 expecting IPSC to rise to within 12 ...
Shares of Century Therapeutics, Inc. (IPSC) have gained 9.7% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term ...
Century Therapeutics (NASDAQ:IPSC – Free Report) had its target price cut by HC Wainwright from $5.00 to $2.00 in a research report report published on Thursday morning,Benzinga reports. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback